瑞思迈 RMD 深 沪
等待开盘 11-07 09:30:00 美东时间
248.74
+3.520
+1.44%
华盛通- 最 高249.94
- 今 开243.40
- 成交量 101.71万股
- 最 低 242.02
- 昨 收 245.22
- 总市值 363.16亿
- 52周最高 293.81
- 市盈率 静 26.16
- 换手率 0.70%
- 52周最低 198.79
- 委 比 12.50%
- 总股本 1.46亿
- 历史最高 293.81
- 量 比 0.83
- 振 幅 3.23%
- 历史最低 5.65
- 每 手 1
- 风险率 20.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ResMed CFO Reports Stock Transactions Under Rule 10b5-1 Plan
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
11-05 06:54
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
ResMed Inc. Files Quarterly Report, Affirms Market Position
An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ...
11-03 05:27
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
11-01 01:26
ResMed declares $0.60 dividend
ResMed (RMD) declares $0.60/share quarterly dividend, in line with previous. Forward yield 0.95% Payable Dec. 18; for shareholders of record Nov. 13; ex-div Nov. 13. See RMD Dividend Scorecard, Yield ...
10-31 20:45
Mizuho Maintains Outperform on ResMed, Lowers Price Target to $300
Mizuho analyst Anthony Petrone maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $310 to $300.
10-31 20:04
财报速睇 | 瑞思迈2025财年Q3营收13.36亿美元，股权持有人应占溢利3.49亿美元
华盛资讯10月31日讯，RESMED INC公司今日公布2025财年Q3业绩，公司Q3营收13.36亿美元，同比增长9.1%，股权持有人应占溢利3.49亿美元，同比增长11.9%。
10-31 18:51
财报速睇 | 瑞思迈2025财年Q3营收13.36亿美元，股权持有人应占溢利3.49亿美元
华盛资讯10月31日讯，RESMED INC公司今日公布2025财年Q3业绩，公司Q3营收13.36亿美元，同比增长9.1%，股权持有人应占溢利3.49亿美元，同比增长11.9%。
10-31 05:09
ResMed Q1 Adj. EPS $2.55 Beats $2.50 Estimate, Sales $1.336B Beat $1.331B Estimate
ResMed (NYSE:RMD) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.50 by 2.04 percent. This is a 15.91 percent increase over earnings of $2.20 per share from the same period
10-31 04:09
